Traws Pharma, Inc.
Traws Pharma, Inc. (TRAW) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 23 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Dec 12, 2025 involved a transaction of 16,419 shares valued at $0.
TRAW Insider Activity Summary
Who Is Buying TRAW Stock?
No significant insider buying has been recorded for TRAW in the recent period.
Who Is Selling TRAW Stock?
No significant insider selling has been recorded for TRAW in the recent period.
Is Traws Pharma, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TRAW is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
TRAW Frequently Asked Questions
Understanding TRAW Insider Activity
Insider trading at Traws Pharma, Inc. (TRAW) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading TRAW stock, having executed 23 transactions in the past 90 days. The most active insider is Mark Patrick Guerin (Executive), who has made 2 transactions totaling $1.0K.
Related Tools
Track Traws Pharma, Inc. Insider Activity
Get notified when executives and directors at TRAW file new Form 4 transactions